Integration of chemotherapy into combined modality therapy of solid tumors: IV. Malignant melanoma
- 31 December 1974
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 1 (4) , 285-304
- https://doi.org/10.1016/s0305-7372(74)80020-4
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Evaluation of l-(2-chloroethyl-3-4-methylcyclohexyl)-l-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45388) and vincristine (NSC 67574) in palliation of disseminated malignant melanomaCancer, 1974
- AdriamycinAnnals of Internal Medicine, 1974
- Combination Chemiotherapy with 5-(3,3 dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and Vincristine (VCR; NSC - 67574) in Metastatic Malignant MelanomaTumori Journal, 1973
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- Hexamethylmelamine—A new drug with activity in solid tumorsPublished by Elsevier ,1973
- The absorption and metabolism of dibromodulcitol in patients with advanced cancerClinical Pharmacology & Therapeutics, 1972
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- Therapeutic effects of hydroxyurea.Experience with 118 patients with inoperable solid tumorsCancer, 1970
- Neoplastic disease. Treatment with vinblastine. A cooperative studyArchives of internal medicine (1960), 1965
- Vinblastine Sulphate in the Treatment of Malignant DiseaseBritish Journal of Cancer, 1965